News
FDA approves LUMAKRAS in combination with Vectibix for chemorefractory KRAS G12C-mutated metastatic colorectal cancer
The U.S. Food and Drug Administration (FDA) has approved Amgen's LUMAKRAS (sotorasib) in combination with Vectibix (panitumumab) for the treatment of adult patients with KRAS G12C-mutated...
AstraZeneca’s Calquence plus chemoimmunotherapy approved in the US for patients with previously untreated mantle...
AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell...
InflaRx gains European Commission approval for GOHIBIC to treat SARS-CoV-2-induced acute respiratory distress syndrome
The European Commission (EC) has granted marketing authorization under exceptional circumstances for InflaRx's GOHIBIC (vilobelimab) for the treatment of adult patients with SARS-CoV-2-induced acute...
